Dr. Atul Gawande is set to become the chief executive of a new health care company being formed by Amazon, Berkshire Hathaway, and JPMorgan Chase.
The company, which has yet to be named, is being launched with lofty ambitions: to find innovative ways to improve health care for employees of the three companies. But its founders have hinted that company-wide solutions could help find solutions to problems across the entire U.S. health system.
Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!
GET STARTEDWhat is it?
STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- Online intelligence briefings
- Frequent opportunities to engage with veteran beat reporters and industry experts
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
I would like to cancel my subscription. How can I do this?
Michael Nussbaum